Skip to main content
PABD logo
PABD
(NASDAQ)
iShares Paris-Aligned Climate Optimized MSCI World ex USA ETF
$64.11-- (--)
Loading... - Market loading

PABD ETF: iShares Paris-Aligned Climate Optimized MSCI World ex USA ETF - Price, Holdings & Analysis

iShares Paris-Aligned Climate Optimized MSCI World ex USA ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$64.11 - $64.13
52-Week High$70.25
52-Week Low$49.12
Open$64.13
Volume344
Average Volume (3M)344
Assets (AUM)311.78M
Expense Ratio0.12%
Total Holdings453
Inception DateFeb 7, 2022
1 Day Change2.61%
1 Month Change-5.93%
6 Month Change1.38%
YTD Change-0.86%
1 Year Change18.27%
52-Week Change18.76%
50-Day MA$66.49
200-Day MA$63.55
RSI50.60
Stochastic %K100.00
Stochastic %D43.57
Annual Dividend$1.77
Dividend Yield2.74%
Last Dividend Ex-DateJun 20, 2026
Dividend Growth YoY20.71%
Years Dividend Growth1

Frequently Asked Questions About iShares Paris-Aligned Climate Optimized MSCI World ex USA ETF

What is the current price of PABD?

The latest PABD price is $64.11. The 52-week range is $49.12–$70.25. PABD has returned 18.8% over the past 52 weeks.

What is the expense ratio for PABD?

PABD's annual expense ratio is 0.12%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.

Does PABD pay dividends?

Yes, PABD pays a 2.74% dividend yield. The last ex-dividend date was 2026-06-20. View full dividend history in the Dividends section.

What are the top holdings of PABD?

PABD's largest holdings are ASML Holding N.V (2.7%), Novartis AG (1.6%), AstraZeneca PLC (1.5%) (combined weight: 5.8%). The fund holds 453 total positions. View the complete portfolio breakdown in the Holdings section.

How does PABD compare to similar ETFs?

Compare PABD (0.12% expense ratio, $312M AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.